Talecris Biotherapeutics Holdings Corp (TLCR:US)
was acquired by GRF:SM
Talecris Biotherapeutics Holdings Corporation provides biopharmaceutical services. The Company develops, produces, and markets plasma-derived protein therapies to treat immune deficiency disorders, infectious diseases, hemophilia, and severe burns. Talecris Biotherapeutics serves critical care patients, health care providers, and markets its products worldwide.